| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 05/26/2010 | EP1153140B9 Protection probes |
| 05/26/2010 | CN1908174B Method of producing L-lysine |
| 05/26/2010 | CN1791433B DNA vaccines against tumor growth and methods of use thereof |
| 05/26/2010 | CN1720324B Improved SS07-polymerase conjugate proteins |
| 05/26/2010 | CN1711279B Epstein Barr virus peptide epitopes, polyepitopes and delivery system therefor |
| 05/26/2010 | CN1659179B System for tracing animal products |
| 05/26/2010 | CN1633237B Novel SPINOSYN-producing polyketide synthases |
| 05/26/2010 | CN1578678B Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 05/26/2010 | CN101712725A New dialyzing technology in preparation process of bacilli calmette-guerin (BCG) polyose nuclear acid |
| 05/26/2010 | CN101712722A Glp-1 fusion proteins |
| 05/26/2010 | CN101712710A LMP1targeted oligonucleotide and application thereof serving as radiotherapeutic sensitizer |
| 05/26/2010 | CN101147807B Substances for preventing and treating autoimmune diseases |
| 05/26/2010 | CN101058595B Ibonucleic acid, and preparation method and application thereof |
| 05/26/2010 | CN101057976B Substances for preventing and treating autoimmune diseases |
| 05/25/2010 | US7723589 Plants and seeds of corn variety CV688430 |
| 05/25/2010 | US7723574 Process for the production of Δ5-unsaturated fatty acids in transgenic organisms |
| 05/25/2010 | US7723573 Rubisco activase with increased thermostability and methods of use thereof |
| 05/25/2010 | US7723572 Polynucleotide encoding polypeptide having aspartate kinase activity; transforming cell for development of nutritionally improved crop plants |
| 05/25/2010 | US7723565 Expression vector comprising nucleotide sequences associated with vernalization-3 gene (VIN-3); controlling flowering in crops; improving heterologous gene expression |
| 05/25/2010 | US7723511 contacting the 5' hydroxyl group of a solid support bound nucleic acid with a phosphite in acetonitrile to form a phosphite diester intermediate, then oxidizing the phosphite diester intermediate with an arylacetyl disulfide in a solvent mixture, to for a a phosphorothioate internucleoside linkage |
| 05/25/2010 | US7723510 MicroRNA molecules |
| 05/25/2010 | US7723509 Conjugated lipophilic group with a modified nucleotide is used to target disease gene, cells, tissue, for drug delivery to target tumor cells; ribose sugar of nucleotide is replaced with a cyclic carrier which has at least one attached phosphate or phosphorothioate group; biodrugs |
| 05/25/2010 | US7723508 Modulation of apolipoprotein (A) expression |
| 05/25/2010 | US7723507 Diagnostic test for Collie Eye Anomaly |
| 05/25/2010 | US7723506 Heat shock protein regulatory sequences for enhancing expression of heterologus genes in cells; improving transcription from exogenous genes |
| 05/25/2010 | US7723505 EAAT2 promoter and uses thereof |
| 05/25/2010 | US7723504 Nontypeable Haemophilus influenzae virulence factors |
| 05/25/2010 | US7723503 nucleotide sequences or complements that encode polypeptides having omega-3 desaturase and delta-12 desaturase enzyme activity, used for making polyunsaturated fatty acids; additives for drugs, nutritional compositions, animal feeds, as well as other products such as cosmetics |
| 05/25/2010 | US7723502 a codon optimized and stabilized polynucleotide that codes for polypeptides; oxidoreductase enzymes exhibiting long-wavelength light emission, as well as improved thermostability and higher expression levels in mammalian cell systems |
| 05/25/2010 | US7723501 polynucleotides tht code for Bcl-2 associated athanogenes (BAG), a family of proteins that can regulate protein folding, useful in modulating chaperone protein activity |
| 05/25/2010 | US7723500 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis; booster vaccines |
| 05/25/2010 | US7723499 polynucleotides that code for polypeptides comprising amino acid sequences that preferentially recognize and bind to angiopoietins |
| 05/25/2010 | US7723498 as biocatalysts in industrial chemical redox reactions, such as the oxidation of aromatic hydrocarbons, for example, toluene, benzene, or nitrobenzene, into industrially desirable products |
| 05/25/2010 | US7723497 polynucleotide having nucleic acid sequences, encoding and expressing calcium-independent phospholipase A2 epsilon (iPLA2 epsilon ); for catalysis and hydrolysis of lipids in living cell biosystem; iPLA2 epsilon as a pharmacological target in drug screening anti-obesity drugs |
| 05/25/2010 | US7723496 Tumor antigen for diagnosis and treatment of cell proliferative disorders |
| 05/25/2010 | US7723495 Amidite for nucleic acid synthesis and nucleic acid synthesizing method |
| 05/25/2010 | US7723481 G protein coupled receptor (GPCR) polypeptide, attached to a detectable label seleacted from green fluorescent polypeptide or a rhodopsin polypeptide, involved in bitter taste transduction; used as additives for foods, beverages and drugs in order to modify T2R-associated bitter taste |
| 05/25/2010 | US7723317 rna interference; apolipoproteins; gene expression inhibition; hypercholesterolemia; hyperlipidemia |
| 05/25/2010 | US7723316 Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases |
| 05/25/2010 | US7723315 A nucleic acid ligand whose sequence optionally includes a 2'-O-methyl modification and/or a 2'-O-fluoro modification, useful for inhibiting coagulation in a host undergoing a therapeutic regime such as surgery or coronary artery bypass |
| 05/25/2010 | US7723312 heat shock protein 27 inhibitors; RNA interference; nuclease resistance |
| 05/25/2010 | US7723298 Cytokine receptor |
| 05/25/2010 | US7723270 comprises a filamentous bacteriophage particle displaying on its surface a binding molecule which has a binding domain able to bind target epitope or antigen; genetic engineering |
| 05/25/2010 | US7723110 Plant cell signaling genes |
| 05/25/2010 | US7723104 Polynucleotide construct having a prostate cancer-specific control sequence including at least 2 of a prostate tissue-specific control sequence; a cancer-specific control sequence; and a two-step transcriptional amplification sequence including a DNA binding domain and an activation domain |
| 05/25/2010 | US7723096 Agonist peptides of carcinoembryonic antigen (CEA) and nucleic acid sequences encoding the agonist peptides |
| 05/25/2010 | US7723093 Used for removing cross contamination from PCR reaction products byreacting a uracil-containing DNA substrate with the uracil-DNA glycosylase at 50 degrees C. or lower, and conducting PCR reaction. |
| 05/25/2010 | US7723091 combination of a mannanase and a carrier that is adapted for oral administration and does not contain an anti-infection agent other than the mannanase; treating or ameliorating the risk of a digestive tract infection, particularly of Eimeria, Cryptosporidium, or Clostridium |
| 05/25/2010 | US7723090 Method of heat-stabilizing α-glucan phosphorylase (GP) |
| 05/25/2010 | US7723087 Preparing transgenic microorganism comprising modified intercellular adhesion (ica) locus and which generates cell surface proteins with altered poly-N-acetyl glucosamine (PNAG) side chain profile for use in vaccine development; bactericides |
| 05/25/2010 | US7723082 Polynucleotides and polypeptides coded by said polynucleotides involved in the synthesis of diketopiperazine derivatives |
| 05/25/2010 | US7723079 Trichoderma reesei glucoamylase and homologs thereof |
| 05/25/2010 | US7723074 Nucleic acid molecules encoding prostaglandin receptor proteins |
| 05/25/2010 | US7723073 Nucleic acid sequences containing a coding sequence for a light chain of an anti-VLA-1 antibody or antigen binding fragment, and a coding sequence for a heavy chain of an anti-VLA-1 antibody or fragment; the light chain and the heavy chain form an antibody or fragment that binds VLA-1 |
| 05/25/2010 | US7723072 Using cadmium-zinc resistance (CZR) protein as modulator for enhancing exogenous gene expression |
| 05/25/2010 | US7723069 Site specific incorporation of phosphoserine into polypeptides using phosphoseryl-tRNA synthetase |
| 05/25/2010 | US7723067 Process for producing transglutaminase |
| 05/25/2010 | US7723051 HT2R75 taste receptor and related assays for identifying human bitter taste modulators |
| 05/25/2010 | US7723040 Detection of HIV-1 by nucleic acid amplification |
| 05/25/2010 | US7723038 Amplification methods |
| 05/25/2010 | US7723036 determining that a human will have a prolonged response period to treatment of follicular lymphoma with Rituximab monoclonal antibody therapy; examining either protein or nucleic acids |
| 05/25/2010 | US7723035 detecting a reduction in gene copy number, by determining gene mutational status, or by detecting a reduction in the RNA transcribed from these genes; inhibition of neoplastic or tumorigenic growth of cancers such as chronic lymphocytic leukemia or prostate cancer cells |
| 05/25/2010 | US7723034 determining that a single nucleotide point mutation in the fourth exon of the nucleic acid sequence encoding dog CLN5 results in the production of a variant soluble lysosomal glycoprotein, specifically CLN5, which exhibits aberrant functional activity |
| 05/25/2010 | US7723033 Prediction of likelihood of cancer recurrence |
| 05/25/2010 | US7723031 replication and amplification of target nucleic acid sequences, in the presence of a bacteriophage protein and a DNA polymerase; genetic engineering |
| 05/25/2010 | US7723028 Diagnostics and therapeutics for osteoporosis |
| 05/25/2010 | US7723027 Using presence of mutation in neuronal sodium channel (SCN1) to diagnose severe myoclonic epilepsy of infancy (SMEI) |
| 05/25/2010 | US7723024 by measuring zinc regulated nucleic acid molecules expression level indicative of sub-optimal fermentation in a beer brewing |
| 05/25/2010 | US7723022 Oligonucleotide containing activated lymphocytes; antibody therap y; skin disorders; antiallergens; respiratory system disorders |
| 05/25/2010 | US7722889 Plasmodium liver stage antigens |
| 05/25/2010 | US7722888 Streptococcus pneumoniae proteins and nucleic |
| 05/25/2010 | US7722882 Live attenuated vaccine against porcine pleuropneumonia |
| 05/25/2010 | US7722880 polynucleotide encodes a protein for inducing an immune response; use as vaccines; drug targeting to specific protein; bactericides; veterinary medicine |
| 05/25/2010 | US7722877 Coccidiosis vaccines |
| 05/25/2010 | US7722875 Antibodies that bind canine pancreatic lipase |
| 05/25/2010 | US7722871 Immunoglobulins devoid of light chains |
| 05/25/2010 | US7722869 purified scFv peptide comprising a VH domain and a VL domain linked by an amino acid spacer, and scFv peptide comprises a substitution of an amino acid in the VH domain at the position corresponding to C28 |
| 05/25/2010 | US7722864 Exhibit altered chondroitin lyase activity or increased resistance to inactivation from stressors including exposure to ultraviolet radiation or heat; administered following a contusion or spinal cord injury to the central nervous system |
| 05/25/2010 | CA2361079C Method for deprotecting oligonucleotides |
| 05/25/2010 | CA2330237C Broad specificity dna damage endonuclease |
| 05/25/2010 | CA2241786C Novel amp activated protein kinase |
| 05/20/2010 | WO2010057217A1 Compositions and methods for increasing cellular uptake of rnai via sid-1 |
| 05/20/2010 | WO2010057203A2 Hdl particles for delivery of nucleic acids |
| 05/20/2010 | WO2010057069A1 Compositions, kits and methods for detection campylobacter nucleic acid |
| 05/20/2010 | WO2010056805A2 Gene knockout mesophilic and thermophilic organisms, and methods of use thereof |
| 05/20/2010 | WO2010056757A1 Biomarkers for assessing atherosclerotic potential |
| 05/20/2010 | WO2010055789A1 Oligonucleotide derivative, labeling agent, and use of the labeling agent |
| 05/20/2010 | WO2010033167A3 Anti-thrombin aptamer formulations and methods for use |
| 05/20/2010 | WO2009152500A4 Methods and compositions for mediating gene silencing |
| 05/20/2010 | US20100125919 Methods and compositions for modulating the mirna pathway |
| 05/20/2010 | US20100125134 Method of separating genomic dna and plasmid dna from each other and kit therefor |
| 05/20/2010 | US20100125101 Immunostimulatory nucleic acid molecules |
| 05/20/2010 | US20100125099 Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly or abnormally expressed gene |
| 05/20/2010 | US20100124786 Novel Nucleotide and Amino Acid Sequences, and Assays and Methods of use Thereof for Diagnosis of Ovarian Cancer |
| 05/20/2010 | US20100124777 Bacterium producing L-glutamic acid and method for producing L-glutamic acid |
| 05/20/2010 | US20100124767 Microarray Synthesis and Assembly of Gene-Length Polynucleotides |
| 05/20/2010 | US20100124765 Sequence amplification with target primers |
| 05/20/2010 | US20100124764 Single chain antibody library design |
| 05/20/2010 | US20100124551 Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same |
| 05/20/2010 | US20100124548 Pharmaceutical product |